Provided by Tiger Trade Technology Pte. Ltd.

RxSIGHT, INC.

6.25
+0.16002.63%
Post-market: 6.250.00000.00%19:36 EDT
Volume:1.54M
Turnover:9.49M
Market Cap:258.73M
PE:-5.49
High:6.31
Open:6.10
Low:6.00
Close:6.09
52wk High:13.22
52wk Low:4.48
Shares:41.40M
Float Shares:36.26M
Volume Ratio:2.46
T/O Rate:4.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1385
EPS(LYR):-0.9533
ROE:-17.35%
ROA:-10.41%
PB:0.98
PE(LYR):-6.56

Loading ...

RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules

GlobeNewswire
·
Jul 27

Rxsight CEO Aziz Mottiwala Files Initial Beneficial Ownership Statement

Reuters
·
Jul 25

RxSight Tarsus CEO Ron Kurtz to depart role, Aziz Mottiwala to succeed

TIPRANKS
·
Jul 16

Rxsight Names Aziz Mottiwala CEO, Ron Kurtz to Become Chief Medical Officer

Reuters
·
Jul 16

Rxsight Inc: not Updating Previously Communicated Financial Guidance in Connection with This Announcement

THOMSON REUTERS
·
Jul 16

Rxsight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.d. as Chief Medical Officer

THOMSON REUTERS
·
Jul 16

Rxsight - Ron Kurtz, M.d. to Resign from Board; Aziz Mottiwala to Join Board

THOMSON REUTERS
·
Jul 16

RxSight reports preliminary Q2 revenue $32M-$34M, consensus $32.07M

TIPRANKS
·
Jul 08

RxSight raises FY26 revenue view to $140M-$160M from $120M-$135M

TIPRANKS
·
Jul 08

RxSight price target lowered to $6.50 from $7.50 at Jefferies

TIPRANKS
·
Jul 08

Rxsight Price Target Maintained with a $11.00/share by Needham

Dow Jones
·
Jul 07

Analysts’ Top Healthcare Picks: Idexx Laboratories (IDXX), RxSight (RXST)

TIPRANKS
·
Jul 07

Swiss Stocks - Factors to Watch on July 7

Reuters
·
Jul 07

RxSight, Alcon Partner on Light-Adjustable Cataract Lenses

TIPRANKS
·
Jul 07

Rxsight Says Q2 Results Hit by More Widespread Competitive Trialing

Reuters
·
Jul 07

Alcon, RxSight announce collaboration to develop adjustable PCIOLs

TIPRANKS
·
Jul 07

Alcon, Rxsight Partner to Develop Adjustable Presbyopia-correcting Intraocular Lenses

Reuters
·
Jul 07

Alcon Notifies Availability of Press Release on Rxsight Collaboration for Adjustable Pciols

Reuters
·
Jul 07

Alcon, Rxsight Collaborate to Develop Adjustable Presbyopia-correcting Intraocular Lenses

Reuters
·
Jul 07

Rxsight Forecasts 2026 Revenue of $140 Million-$160 Million, Cuts Sales Outlook to $110 Million-$120 Million

Reuters
·
Jul 07